Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY:BMY)

54.03 -0.20 (-0.37%)
Streaming Delayed Price Updated: 9:56 AM EST, Dec 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,356,088
Open 54.07
Bid (Size) 54.03 (100)
Ask (Size) 54.04 (300)
Prev. Close 54.23
Today's Range 53.87 - 54.49
52wk Range 42.52 - 63.33
Shares Outstanding 2,222,113,553
Dividend Yield 4.59%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Why Bristol-Myers Squibb (BMY) Stock Is Up Today
Shares of biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) jumped 3.7% in the afternoon session after BofA Securities upgraded the company's stock from "Neutral" to "Buy" and increased its... 
Via StockStory
News headline image
Stay informed with the top movers within the S&P500 index on Monday. ↗
Stay informed about the performance of the S&P500 index in the middle of the day on Monday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill

Performance

YTD
-4.9%
-4.9%
1 Month
+15.4%
+15.4%
3 Month
+16.6%
+16.6%
6 Month
+14.4%
+14.4%
1 Year
-3.3%
-3.3%

More News

Read More
News headline image
Bristol Myers Squibb (BMS): Navigating the Patent Cliff with a Renewed Pipeline and Strategic Acquisitions
Via PredictStreet
Topics Intellectual Property Lawsuit Supply Chain
News headline image
Top S&P500 movers in Monday's pre-market session ↗
Via Chartmill
News headline image
2 Dividend Stocks to Double Up on Right Now ↗
Via The Motley Fool
Topics Economy Intellectual Property
News headline image
The Smartest Dividend Stocks to Buy With $1,000 Right Now ↗
Via The Motley Fool
Topics Economy Intellectual Property
News headline image
Which S&P500 stocks are moving on Friday? ↗
Via Chartmill
News headline image
Why Bristol-Myers Squibb (BMY) Stock Is Up Today
Via StockStory
Topics Artificial Intelligence Supply Chain
News headline image
Top S&P500 movers in Friday's session ↗
Via Chartmill
News headline image
The Best Turnaround Stock to Invest $1,000 in Right Now ↗
Via The Motley Fool
News headline image
U.S. Food and Drug Administration (FDA) Grants Priority Review to Bristol Myers Squibb's Application for Opdivo® (nivolumab) Plus Chemotherapy Combination for Classical Hodgkin Lymphoma
From Bristol Myers Squibb
Via Business Wire
News headline image
Great Rotation: Tech Exodus Fuels Dow's Record Run While Nasdaq Struggles
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
3 Unpopular Stocks with Questionable Fundamentals
Via StockStory
News headline image
Bristol Myers Squibb Announces Dividend Increase
From Bristol Myers Squibb
Via Business Wire
News headline image
2 Pharmaceutical Stocks to Buy at a Discount ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
1 Large-Cap Stock on Our Buy List and 2 We Turn Down
Via StockStory
News headline image
Bristol Myers Squibb Advances Lymphoma Research with New Targeted Protein Degradation and Cell Therapy Data at ASH 2025
From Bristol Myers Squibb
Via Business Wire
News headline image
Do These 3 Healthcare Stocks Need a Checkup? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL)
From Bristol Myers Squibb
Via Business Wire
News headline image
3 Stocks Under $50 We’re Skeptical Of
Via StockStory
News headline image
Which S&P500 stocks are moving on Wednesday? ↗
Via Chartmill
News headline image
What's going on in today's session: S&P500 movers ↗
Via Chartmill
News headline image
Bristol Myers Stock Jumps As Wall Street Backs Added Enrollment In Alzheimer’s Trial — Retail Calls It ‘Worth A Play’ ↗
Via Stocktwits
News headline image
These S&P500 stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
Bristol Myers Squibb Announces Continuation of ADEPT-2 Phase 3 Study in Psychosis Associated with Alzheimer's Disease
From Bristol Myers Squibb
Via Business Wire

Frequently Asked Questions

Is Bristol-Myers Squibb publicly traded?
Yes, Bristol-Myers Squibb is publicly traded.
What exchange does Bristol-Myers Squibb trade on?
Bristol-Myers Squibb trades on the New York Stock Exchange
What is the ticker symbol for Bristol-Myers Squibb?
The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
What is the current price of Bristol-Myers Squibb?
The current price of Bristol-Myers Squibb is 54.03
When was Bristol-Myers Squibb last traded?
The last trade of Bristol-Myers Squibb was at 12/17/25 09:56 AM ET
What is the market capitalization of Bristol-Myers Squibb?
The market capitalization of Bristol-Myers Squibb is 120.06B
How many shares of Bristol-Myers Squibb are outstanding?
Bristol-Myers Squibb has 120B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.